(Q42687692)

English

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

scientific article published on 13 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial (English)

1 reference

Europe PubMed Central

4 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Willem J M Dewilde

1

1 reference

Europe PubMed Central

4 November 2017

Tom Oirbans

2

1 reference

Europe PubMed Central

4 November 2017

Freek W A Verheugt

3

1 reference

Europe PubMed Central

4 November 2017

Johannes C Kelder

4

1 reference

Europe PubMed Central

4 November 2017

Bart J G L De Smet

5

1 reference

Europe PubMed Central

4 November 2017

Jean-Paul Herrman

6

1 reference

Europe PubMed Central

4 November 2017

Tom Adriaenssens

7

1 reference

Europe PubMed Central

4 November 2017

Mathias Vrolix

8

1 reference

Europe PubMed Central

4 November 2017

Antonius A C M Heestermans

9

1 reference

Europe PubMed Central

4 November 2017

Marije M Vis

10

1 reference

Europe PubMed Central

4 November 2017

Jan G P Tijsen

11

1 reference

Europe PubMed Central

4 November 2017

Arnoud W van 't Hof

12

1 reference

Europe PubMed Central

4 November 2017

Jurriën M ten Berg

13

1 reference

Europe PubMed Central

4 November 2017

WOEST study investigators

14

1 reference

Europe PubMed Central

4 November 2017

language of work or name

0 references

publication date

13 February 2013

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

381

1 reference

Europe PubMed Central

4 November 2017

1107-1115

1 reference

Europe PubMed Central

4 November 2017

9872

1 reference

Europe PubMed Central

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin, aspirin, or both after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Societ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleeding risk assessment and management in atrial fibrillation patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of dual antiplatelet therapy after implantation of drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962177-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)62177-1

1 reference

https://api.fatcat.wiki/v0/release/xgdl6klfyre75ml24ve6crj4e4

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_xgdl6klfyre75ml24ve6crj4e4

1 reference

https://api.fatcat.wiki/v0/release/xgdl6klfyre75ml24ve6crj4e4

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/xgdl6klfyre75ml24ve6crj4e4

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42687692&oldid=1965570983"